» Articles » PMID: 22351374

Effect of Comorbid Conditions on Adherence to Colorectal Cancer Screening

Overview
Journal J Cancer Educ
Publisher Springer
Date 2012 Feb 22
PMID 22351374
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Potential barriers to colorectal cancer (CRC) screening include preexisting medical conditions (comorbidities), physician recommendation, psychosocial factors, and screening preparedness. This study's purpose was to investigate the impact of comorbid conditions on CRC screening among African Americans. A stage-matched randomized clinical trial was performed. Asymptomatic African Americans over age 50, with a primary care physician, and eligible for CRC screening were recruited at The Mount Sinai Hospital from 2005 to 2008. One hundred sixty-one patients were assessed for referral for, and completion of, CRC screening, comorbid conditions, "readiness to change," and number of physician visits within the observation period. Data was compared to a pretrial index to predict the likely effect of comorbid conditions on CRC screening. One hundred fifty-nine patients completed the study; 108 (68.9%) were referred for and 34 (21.2%) completed CRC screening. No demographic characteristics were associated with CRC screening completion. CRC screening referrals were similar for all patients, regardless of comorbidities or clinical visits. Comorbidities rated as having extreme influence on CRC screening showed a trend toward lower screening rates. There was a significant increase in screening rates among participants in advanced stages of readiness at enrollment. These data suggest that while comorbidities did not predict colonoscopy completion, they may play a role in concert with other factors. This is the only study to assess the effect of screening colonoscopy in an African American primary care setting. We must continue to explore interventions to narrow the disparate gap in screening and mortality rates.

Citing Articles

Prevalence and predictors of colorectal cancer screening in the United States: evidence from the HINTS database 2018 to 2020.

Atarere J, Haas C, Akhiwu T, Delungahawatta T, Pokharel A, Adewunmi C Cancer Causes Control. 2023; 35(2):335-345.

PMID: 37737304 DOI: 10.1007/s10552-023-01795-8.


Low Socioeconomic Status Associated with Poor Cancer Screening Perceptions in Malaysia: Analysis of Determinant of Health among General Population.

Shah S, Mahmood M, Ahmad N Asian Pac J Cancer Prev. 2020; 21(11):3137-3144.

PMID: 33247668 PMC: 8033111. DOI: 10.31557/APJCP.2020.21.11.3137.


Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study.

Guiriguet C, Pera G, Castells A, Toran P, Grau J, Rivero I BMC Cancer. 2017; 17(1):524.

PMID: 28784093 PMC: 5547546. DOI: 10.1186/s12885-017-3516-x.


Barriers and facilitators associated with colonoscopy completion in individuals with multiple chronic conditions: a qualitative study.

Sultan S, Partin M, Shah P, LeLaurin J, Freytes I, Nightingale C Patient Prefer Adherence. 2017; 11:985-994.

PMID: 28579761 PMC: 5449171. DOI: 10.2147/PPA.S127862.


Risk factors of nonadherence to colonoscopy surveillance after polypectomy and its impact on clinical outcomes: a KASID multicenter study.

Tae C, Moon C, Kim S, Jung S, Eun C, Park J J Gastroenterol. 2016; 52(7):809-817.

PMID: 27830330 DOI: 10.1007/s00535-016-1280-3.


References
1.
Johnson C, Chen M, Toledano A, Heiken J, Dachman A, Kuo M . Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med. 2008; 359(12):1207-17. PMC: 2654614. DOI: 10.1056/NEJMoa0800996. View

2.
Schoenfeld P, Cash B, Flood A, Dobhan R, Eastone J, Coyle W . Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med. 2005; 352(20):2061-8. DOI: 10.1056/NEJMoa042990. View

3.
Winawer S, Zauber A, OBrien M, Ho M, Gottlieb L, Sternberg S . Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med. 1993; 328(13):901-6. DOI: 10.1056/NEJM199304013281301. View

4.
Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View

5.
Christie J, Jandorf L, Itzkowitz S, Halm E, Freeman K, King S . Sociodemographic correlates of stage of adoption for colorectal cancer screening in African Americans. Ethn Dis. 2009; 19(3):323-9. PMC: 2859842. View